With New Sleeping Pill, New Acceptability?
Get ready for the next big thing, a pill for insomnia designed for long-term use. This is a huge market that the pharmaceuticals would love to further exploit, since when one starts on sleeping pills, they are unable or unwilling to stop (think PPIs for GERD). Of course, the big marketing push is coming:
Sepracor, a still unprofitable company based in Marlborough, Mass., plans to say in its advertisements that Lunesta can be used “night after night after night,” W. James O’Shea, the president, told securities analysts in a conference call yesterday.He said 1,250 sales representatives would call on doctors and the company would spend at least $60 million next year to advertise to consumers, including on prime-time and cable television.
Although we know that cognitive behaviour therapy works better than pills, it is not readily available – which is what the drug company is counting on.
Medpundit also chimes in on this.
Related posts:
- Generic acetaminophen recalled
- ER crisis in Tuscon
- UnitedHealth: It gets worse
- Taking the malpractice fight to the waiting room
- On-call hospital tips
- Use of the on-call physician
- When will we have a safe and effective prescription diet pill?
KevinMD.com on Facebook
{ 4 comments }
Hey Kevin,
Why is cognitive therapy not readily available?
At least in my area, it is difficult to get an appointment with a psychologist or psychiatrist, and patients are not willing to follow-through with this approach. They come in asking for a pill – the so-called “quick fix”.
Will CBT stop snoring? And does beating someone with a rolling pin every time they snore count as therapy? If the answers are no, I might need some drugs.
Lunesta will be veruy popular in my opinion because it is the first sleeping aid that is designed for long-term use and also is narcotic-free. However, time will be the best judge.
Comments on this entry are closed.